A share price of Astrazeneca plc ADR [AZN] is currently trading at $83.77, up 3.23%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AZN shares have gain 1.74% over the last week, with a monthly amount drifted -1.89%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Deutsche Bank downgraded its rating to Sell on October 16, 2025. On April 15, 2025, Exane BNP Paribas initiated with an Outperform rating and assigned a price target of $75 on the stock. UBS upgraded its rating to a Buy. Morgan Stanley initiated its recommendation with a Overweight. UBS upgraded its rating to Neutral for this stock on November 20, 2024. In a note dated November 06, 2024, Deutsche Bank upgraded a Hold rating on this stock.
Astrazeneca plc ADR experienced fluctuations in its stock price throughout the past year between $61.24 and $86.57. Currently, Wall Street analysts expect the stock to reach $97 within the next 12 months. Astrazeneca plc ADR [NASDAQ: AZN] shares were valued at $83.77 at the most recent close of the market. An investor can expect a potential return of 15.79% based on the average AZN price forecast.
Analyzing the AZN fundamentals
Trailing Twelve Months sales for Astrazeneca plc ADR [NASDAQ:AZN] were 56.59B which represents 13.06% growth. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.18%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.2 and Total Capital is 0.15. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.73.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 83.09 points at the first support level, and at 82.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 84.74, and for the 2nd resistance point, it is at 85.70.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Astrazeneca plc ADR [NASDAQ:AZN] is 0.86. Also, the Quick Ratio is 0.67, while the Cash Ratio stands at 0.21. Considering the valuation of this stock, the price to sales ratio is 4.59, the price to book ratio is 5.81 and price to earnings (TTM) ratio is 31.42.
